 Shares of Novavax Inc. NVAX, 2.95 rallied 1.9 in morning trading Wednesday, after the biotechnology company said its protein-based COVID-19 vaccine booster was granted emergency use authorization EUA for adults. The booster shot is OKd for people at least 18 years old who have completed primary vaccinations. 